186 results on '"Kuscu, Cem"'
Search Results
2. Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCR
3. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
4. Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31
5. Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9.
6. Applications of CRISPR technologies in transplantation
7. Exogenous mitochondrial transfer increases energy expenditure and attenuates adiposity gains in mice with diet-induced obesity
8. Unveiling APOL1 Haplotypes: A Novel Classification Through Probe-Independent Quantitative Real-Time PCR
9. Using CRISPR Gene Editing to Prevent Accumulation of Lipids in Hepatocytes
10. Circulating microRNA Profiles for Premature Cardiovascular Death in Patients with Kidney Failure with Replacement Therapy
11. Technical advancements in epigenomics and applications in transplantation
12. Single-cell RNA sequencing reveals peripheral blood mononuclear immune cell landscape associated with operational tolerance in a kidney transplant recipient
13. Supplemental Methods and References from miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14
14. Data from miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14
15. Supplementary Methods, Figure Legends 1-3, Tables 1-2 from Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9
16. Data from Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9
17. Supplementary Figure 1 from Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9
18. Supplementary Figures 2-3 from Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9
19. Key Hepatoprotective Roles of Mitochondria in Liver Regeneration
20. CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
21. Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer
22. Mitochondrial Role in Oncogenesis and Potential Chemotherapeutic Strategy of Mitochondrial Infusion in Breast Cancer
23. A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease
24. P8.008: Single Nuclei Profiling of Focal and Segmental Glomerulosclerosis From Human Allografts
25. P8.007: Single Nuclei RNA-Sequencing Unravels Complex Renal And Immune Cells Signaling Driving Fibrosis in Kidney Allografts
26. Tip60 acetylation of histone H3K4 temporally controls chromosome passenger complex localization
27. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
28. MicroRNAs: Novel Targets in Hepatic Ischemia–Reperfusion Injury
29. Pyrosequencing Analysis for Breast Cancer DNA Methylome
30. A Functional Variant on 9p21.3 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B‐AS1
31. Integrative Analyses of Circulating Small RNAs and Kidney Graft Transcriptome in Transplant Glomerulopathy
32. Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury
33. Alternatively spliced Robo2 isoforms in zebrafish and rat
34. Technical advancements in epigenomics and applications in transplantation
35. A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes
36. Unraveling the Role of KIAA1199, a Novel Endoplasmic Reticulum Protein, in Cancer Cell Migration
37. FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury
38. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
39. ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer
40. Additional file 3: of Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer
41. Additional file 1: of Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer
42. CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia
43. Temporal and Spatial Epigenome Editing Allows Precise Gene Regulation in Mammalian Cells
44. A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes.
45. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells.
46. CRISPR-STOP: Gene silencing through base editing-induced nonsense mutations
47. Corrigendum to: “Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers” [EBioMedicine 8 (2016) 117–131]
48. Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9
49. CRISPR-Cas9-AID base editor is a powerful gain-of-function screening tool
50. Mitochondrial Infusion Attenuates Cisplatin-Induced AKI by Inducing Mitochondrial Dynamics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.